Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002932 · ClinicalTrials.gov registry record · Phase 2
Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck
A Phase 2 study of Head and Neck Cancer, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
- 13
- Study locations
NCT00002932: Completed Phase 2 study of Head and Neck Cancer, sponsored by Radiation Therapy Oncology Group.
NCT00002932 is a Phase 2 study of Head and Neck Cancer that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 60 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (77% lower). The trial reports 13 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002932, a Phase 2 study of Head and Neck Cancer, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
- 13
- Study locations
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of cisplatin and radiation therapy in treating patients with stage IV cancer of the head and neck.
Conditions Studied
Interventions
- DRUG cisplatin
- RADIATION radiation therapy
Study Locations (13)
Tennessee
- CCOP - Baptist Cancer Institute - Memphis
- University of Tennessee, Memphis Cancer Center - Memphis
- Vanderbilt Cancer Center - Nashville
California
- University of California San Diego Cancer Center - La Jolla
- UCSF Cancer Center and Cancer Research Institute - San Francisco
Vermont
- Fletcher-Allen Health Care - Burlington
- Green Mountain Oncology Group - Rutland
Washington
- University Cancer Center - Seattle
- University of Washington Neutron Facility and Cancer Center - Seattle
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
Louisiana
- MBCCOP - LSU Medical Center - New Orleans
Maryland
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland - Baltimore
Virginia
- Naval Medical Center, Portsmouth - Portsmouth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 1997-05 |
| Est. Completion | 2005-03 |
| Phase | Phase 2 |
What the finished NCT00002932 record still lists
NCT00002932 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 2 interventions - of which cisplatin is the first listed.
NCT00002932 lists 13 locations in 8 states (Tennessee, California, Vermont).
Frequently Asked Questions
What is clinical trial NCT00002932 about?
NCT00002932 is a clinical study titled "Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effe...
What is the current status of trial NCT00002932?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 1997-05. Estimated completion is 2005-03.
What conditions does trial NCT00002932 study?
This clinical trial studies the following conditions: Head and Neck Cancer.
What interventions are being tested in trial NCT00002932?
The interventions under investigation include: cisplatin (DRUG), radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00002932?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002932 being conducted?
This trial has 13 study locations across California, Iowa, Louisiana, Maryland, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00002932's enrollment target sits among peer trials
60 115th of 250 higher than 131 of 250 other Head and Neck Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Head and Neck Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase II Panitumumab-IRDye800 in Head & Neck Cancer
RECRUITING · Phase 2
-
ATATcH Alternating Treatment Plans for Advanced Cancer
RECRUITING · Phase 2
-
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
RECRUITING · Phase 2
-
Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)
RECRUITING · Phase 2
-
PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC
RECRUITING · Phase 2
-
A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia